Lenovo 2014 Annual Report Download - page 168

Download and view the complete annual report

Please find page 168 of the 2014 Lenovo annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 199

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80
  • 81
  • 82
  • 83
  • 84
  • 85
  • 86
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • 94
  • 95
  • 96
  • 97
  • 98
  • 99
  • 100
  • 101
  • 102
  • 103
  • 104
  • 105
  • 106
  • 107
  • 108
  • 109
  • 110
  • 111
  • 112
  • 113
  • 114
  • 115
  • 116
  • 117
  • 118
  • 119
  • 120
  • 121
  • 122
  • 123
  • 124
  • 125
  • 126
  • 127
  • 128
  • 129
  • 130
  • 131
  • 132
  • 133
  • 134
  • 135
  • 136
  • 137
  • 138
  • 139
  • 140
  • 141
  • 142
  • 143
  • 144
  • 145
  • 146
  • 147
  • 148
  • 149
  • 150
  • 151
  • 152
  • 153
  • 154
  • 155
  • 156
  • 157
  • 158
  • 159
  • 160
  • 161
  • 162
  • 163
  • 164
  • 165
  • 166
  • 167
  • 168
  • 169
  • 170
  • 171
  • 172
  • 173
  • 174
  • 175
  • 176
  • 177
  • 178
  • 179
  • 180
  • 181
  • 182
  • 183
  • 184
  • 185
  • 186
  • 187
  • 188
  • 189
  • 190
  • 191
  • 192
  • 193
  • 194
  • 195
  • 196
  • 197
  • 198
  • 199

166 Lenovo Group Limited 2013/14 Annual Report
NOTES TO THE FINANCIAL STATEMENTS
17 Intangible assets
(a) Group
Goodwill
(Note (c))
Trademarks
and trade
names
(Note (c))
Internal
use
software
Customer
relation-
ships
Patent and
technology
(Note (d)) Total
US$’000 US$’000 US$’000 US$’000 US$’000 US$’000
At April 1, 2012
Cost 2,281,069 585,444 578,965 116,261 119,492 3,681,231
Accumulated amortization and
impairment losses 130,000 337,131 20,493 102,402 590,026
Net book amount 2,281,069 455,444 241,834 95,768 17,090 3,091,205
Year ended March 31, 2013
Opening net book amount 2,281,069 455,444 241,834 95,768 17,090 3,091,205
Exchange adjustment (78,358) (7,742) 479 (15,013) (1,196) (101,830)
Additions 56,078 1,900 57,978
Transfer from
construction-in-progress 99,260 99,260
Disposals (3,124) (3,124)
Amortization (590) (100,570) (9,261) (7,086) (117,507)
Acquisition of subsidiaries 201,269 13,745 876 66,046 18,500 300,436
Closing net book amount 2,403,980 460,857 294,833 137,540 29,208 3,326,418
At March 31, 2013
Cost 2,403,980 591,447 724,817 173,268 137,906 4,031,418
Accumulated amortization and
impairment losses 130,590 429,984 35,728 108,698 705,000
Net book amount 2,403,980 460,857 294,833 137,540 29,208 3,326,418
Year ended March 31, 2014
Opening net book amount 2,403,980 460,857 294,833 137,540 29,208 3,326,418
Exchange adjustment (47,685) 4,086 (641) 908 (632) (43,964)
Reclassification (59,680) 59,680
Additions 111 61,001 395 48,037 109,544
Transfer from
construction-in-progress 54,337 4,092 13,041 71,470
Disposals (12,111) (562) (12,673)
Amortization (2,011) (110,883) (11,937) (20,613) (145,444)
Acquisition of subsidiaries 33,527 (1,514) 2,152 34,165
Closing net book amount 2,389,822 461,529 226,856 133,150 128,159 3,339,516
At March 31, 2014
Cost 2,389,822 594,084 715,182 181,468 302,686 4,183,242
Accumulated amortization and
impairment losses 132,555 488,326 48,318 174,527 843,726
Net book amount 2,389,822 461,529 226,856 133,150 128,159 3,339,516
Amortization of US$18,281,000 (2013: US$25,206,000), US$8,263,000 (2013: US$9,673,000), US$91,312,000 (2013:
US$75,948,000) and US$27,588,000 (2013: US$6,680,000) are included in the ‘cost of sales’, ‘selling and distribution
expenses’, ‘administrative expenses’ and ‘research and development expenses’ in the consolidated income statement
respectively.